SCHEMBL7100438

SCHEMBL7100438

[O-][S+]1C=Cc2nc3ncncc3nc2N1

nearest known ligand 0.37

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PIK3CG P48736 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12005283 0.70 PIK3CG (0.33) PIK3CG
SCHEMBL3292267 0.67 PIK3CG (0.47) PIK3CG
SCHEMBL1378685 0.65 PIK3CG (0.46) PIK3CG
SCHEMBL30124132 0.61 EGFR (0.54) PIK3CG
SCHEMBL35632 0.61 EGFR (0.54) PIK3CG
SCHEMBL3536096 0.59 PIK3CG (0.67) PIK3CG
SCHEMBL30290978 0.58 PIK3CG (0.41) PIK3CG
SCHEMBL30611771 0.58 PIK3CG (0.41) PIK3CG
SCHEMBL2490862 0.58 PIK3CG (0.41) PIK3CG
SCHEMBL2049528 0.58 EGFR (0.45) PIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1357114-A1 Substituted pyrimidin-2,4(1H,3H)-diones as inhibitors of Matrix Metalloproteinases (MMP) IBFB GmbH Privates Institut für biomedizinische Forschung und Beratung (DE) 2003-10-29 EP disclosed